MET Development

MET Development

Specialized Medical & Pharmaceutical Consultations

Areas of Medical Expertise

Stem Cell/Bone Marrow Transplant COnsultation

Assess need/indication for autologous or allogeneic stem cell/bone marrow transplants for any malignancy, immune deficiency, connective tissue disease or hematologic disorder.

Protocol Reviews and Revisions

With almost 40 years of experience writing and reviewing protocols at the level of Phase 1, Phase 2, Phase 3 and post-marketing Phase 4 studies, Dr. Trigg will review protocols for consistency and their completeness.

Treatment of Acute Lymphoblastic/Lymphocytic Leukemia

Assess treatment regimens and protocols for those undergoing initial treatment or for those undergoing treatment for resistant/refractory disease.

Bacteriophage Treatment of Serious Infections

As Chief Medical Officer of Adaptive Phage Therapeutics, Dr. Trigg provides reviews of available clinical experience worldwide and provides consultation on the use of phage for significant infections.

Medical Affairs Consultation for Pharmaceutical Industry

Reviews of scientific and medical information in the area of oncology or immune related disorders, for use with multiple levels of health care providers and consumers.

Non-clinical Careers for Physicians

After a 30+ year academic career, Dr. Trigg is able to provide guidance and consultation to those in the medical profession interested in pursuing a non-clinical career, particularly in the pharmaceutical industry.



Let's Chat.

Use the form below to contact us regarding your medical & pharmaceutical consultation needs. Please be as detailed as possible. To help us best service your inquiry, we recommend that you first describe the issue you’re having before telling us what you want to achieve. You may also email or call us to make an appointment. If you prefer to send an attachment instead, please send a direct email to Dr. Trigg along with any and all attachments.

Name *
Please do not include confidential or sensitive information in your message.